Desferrioxamine 2g powder for solution for injection vials
NHS hospitals in England used £16,171,185 of indicative cost of Desferrioxamine 2g powder for solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is down 6.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Desferrioxamine 2g powder for solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Desferrioxamine 2g powder for solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Whittington Health Nhs Trust | £2,375,185 |
| Manchester University Nhs Ft | £2,142,448 |
| Barts Health Nhs Trust | £1,944,232 |
| Royal Free London Nhs Foundation Trust | £890,222 |
| King's College Hpl Nhs Foundation Trust | £794,729 |
| Guy's & St Thomas' Nhs Foundation Trust | £658,325 |
| Bradford Teaching Hospitals Nhs Ft | £649,368 |
| Leeds Teaching Hpls Nhs Trust | £574,075 |
| Sandwell And West Birmingham Hpls Trust | £533,676 |
| Barkinghavering & Redbridge Hpls Trst | £478,629 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.